Seatrium Limited stock rebounds as SGX traders eye Feb 28 Maersk vessel deadline
21 January 2026
1 min read

Seatrium Limited stock rebounds as SGX traders eye Feb 28 Maersk vessel deadline

Singapore, Jan 21, 2026, 15:40 SGT — Regular session

  • Seatrium shares inched 0.5% higher to S$2.13, while the STI slipped a bit.
  • The stock comes after two straight sessions of losses, with heavy turnover and a surge in short selling.
  • Attention is on a wind-vessel delivery set for Feb. 28, tied to a $360 million payment

Seatrium shares rose 0.5% to S$2.13 by 3:29 p.m., recovering from losses over the last two days. The stock fell 3.6% on Jan. 19 and slid another 1.9% on Jan. 20. Tuesday’s trading volume hit around 19.7 million shares, with short selling making up about a third. 1

The rebound comes as investors wrestle with industrial stocks jolted by new tariff-related volatility. “Global investors are taking these threats seriously,” Jack Ablin, chief investment strategist at Cresset Capital, told Reuters, referring to Washington’s latest tariff warnings on Greenland. 2

Timing matters for Seatrium. The stock has been trading like a high-beta play on risk appetite this week, but the key moment is still ahead: the handover of a wind-turbine installation vessel. That handover will determine when cash starts flowing and how any ongoing legal disputes unfold.

Seatrium settled a dispute last month with a Maersk Offshore Wind affiliate over a $475 million vessel contract, after Maersk canceled it in October, citing delays. Under the deal, the buyer must pay the remaining $360 million, with $250 million financed through an interest-bearing credit facility that can last up to 10 years. Repayments will be made from the vessel’s cash flow, according to Reuters. 3

Seatrium disclosed in its SGX filing that the vessel will be delivered by Feb. 28, 2026, with the buyer expected to take possession by that date. At the time of the announcement, the project was about 99.8% complete. The company added that the resolution is unlikely to have a material impact on net tangible assets or earnings per share for the year ending Dec. 31, 2025. 4

Citi analyst Luis Hilado told The Business Times the market took the dispute resolution “positively” as it removed a legal uncertainty. He highlighted the company’s robust order momentum, which could set the stage for a stronger financial year in 2026, the report said. 5

The structure of the deal, though, might cause issues. The credit facility functions essentially as a loan secured by the vessel, with repayments linked to operational cash flow. Any setbacks in delivery, dips in utilisation, or surging expenses could swiftly throw off the cash flow projections. 6

Flows are taking center stage over fundamentals. Singapore’s cyclicals have shifted alongside broad risk moves as global markets digest tariff updates, with Seatrium moving in step.

Seatrium will release its upcoming earnings on Feb. 20, per Investing.com. 7

The market’s attention is zeroed in on two main issues: updates on the Feb. 28 delivery and if tariff threats actually materialize. Trump revealed plans to slap a 10% import tariff starting Feb. 1 on goods from several European countries, Reuters reports — a looming threat that could shake markets next week. 8

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Keppel share price slips as SGX:BN4 eases for a second session
Previous Story

Keppel share price slips as SGX:BN4 eases for a second session

Jardine Matheson share price today: J36 slips as buybacks and Mandarin Oriental delisting land
Next Story

Jardine Matheson share price today: J36 slips as buybacks and Mandarin Oriental delisting land

Go toTop